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Opposing Roles for Endogenous BDNF and NT-3
in Regulating Cortical Dendritic Growth
A. Kimberley McAllister,*² Lawrence C. Katz,*² nervous system development are likely to be more com-
plex, as central neurons commonly respond to severaland Donald C. Lo²
*Howard Hughes Medical Institute neurotrophic factors, and their survival and differentia-
tion in vitro requires multiple neurotrophic factors²Department of Neurobiology
Duke University Medical Center (Snider, 1994; Meyer-Franke et al., 1995). In cerebral
cortex, neurons in each layer express several neuro-Durham, North Carolina, 27710
trophins and Trk receptors (Merlio et al., 1992; Kokaia
et al., 1993; Miranda et al., 1993; Ringstedt et al., 1993;
Snider, 1994; Lindsay et al., 1994). One explanation forSummary
this is that multiple neurotrophins provide redundant
growth and differentiation signals, buta more interestingNeurons within each layer of cerebral cortex express
multiple members of the neurotrophin family and their possibility is that the developing cortex uses multiple
neurotrophic signals to direct distinct aspects of neu-corresponding receptors. This multiplicity could pro-
vide functional redundancy; alternatively, different ronal growth and differentiation.
We have addressed this issue by studying how en-neurotrophins may direct distinct aspects of cortical
neuronal growth and differentiation. By neutralizing dogenous neurotrophins regulate the dendritic growth
of pyramidal neurons. During development, pyramidalendogenous neurotrophins in organotypic slices of
developing cortex with Trk receptor bodies (Trk±IgGs), neurons undergo highly-regulated patterns of dendritic
growth that result in the stereotypic neuronal morpholo-we found that BDNF and NT-3 oppose one another in
regulating the dendritic growth of pyramidal neurons. gies and interconnections characteristic of each cortical
layer (Ramon y Cajal, 1929; Miller, 1988; Koester andIn layer 4, both endogenous and exogenous NT-3 in-
hibited the dendritic growth stimulated by BDNF. In O'Leary, 1992). Each of the four neurotrophins, when
applied exogenously, dramatically alter such dendriticcontrast, in layer 6 both endogenous and exogenous
BDNF inhibited dendritic growth stimulated by NT-3. growth (McAllister et al., 1995); however, the normal
roles of endogenous neurotrophins in regulating corticalThese antagonistic actions of endogenous BDNF and
NT-3 provide a mechanism by which dendritic growth dendritic growth are unknown.
Here, we demonstrate that endogenous neurotro-and retraction can be dynamically regulated during
cortical development, and suggest that the multiple phins, like exogenous neurotrophins, can either stimu-
late or inhibit dendritic growth. Furthermore, in layersneurotrophins expressed in developing cortex repre-
sent distinct components of an extracellular signaling 4 and 6, endogenous BDNF and NT-3 have opposing
actions in regulating dendritic growth. BDNF stimulatessystem for regulating dendritic growth.
growth in layer 4 neurons, while NT-3 potently inhibits
BDNF-dependent growth. In contrast, in layer 6, NT-3
stimulates dendritic growth, and BDNF inhibits its ac-Introduction
tion. Thus, in cortex, multiple neurotrophins are used
instructively to direct different aspects of dendriticAlthough the neurotrophins are a family of four structur-
ally related proteins with similar functions in promoting growth as individual neurons and neural circuits de-
velop.neuronal survival and/or differentiation in the peripheral
nervous system, their roles in the central nervous system
remain controversial. In the periphery, the survival and Results
differentiation of particular neurons generally depends
on individual neurotrophins (reviewed by Snider, 1994; Neurotrophin signaling in organotypic brain slices of P14
ferret visual cortex was manipulated in two ways: byLindsayet al., 1994). Theroles of neurotrophins in central
Figure 1. Exogenous BDNF and NT-3 Have
Reciprocal Actions on Dendritic Growth in
Layers 4 and 6 of Developing Visual Cortex
Changes in dendritic complexity of pyramidal
neurons from layers 4 and 6 are summarized
for visual cortical slices treated for 36 hr with
200 ng/ml BDNF and NT-3 (see also McAllis-
ter et al., 1995). Dendritic complexity is de-
scribed in terms of a dendrite modification
index (DMI; see Experimental Procedures): a
zero value on these graphs indicates no sta-
tistically significant difference from untreated
neurons, an increase in DMI reflects an in-
crease in dendritic complexity, and a decrease in DMI reflects a decrease in dendritic complexity.
(A) Exogenous BDNF stimulates dendritic growth by almost doubling the complexity of basal dendrites of layer 4 neurons, while exogenous
NT-3 has essentially no effect.
(B) In contrast, growth of layer 6 basal dendrites is stimulated by NT-3 but inhibited by BDNF.
Figure 2. Opposite Effects of Endogenous BDNF and NT-3 on Dendritic Growth of Layer 4 Neurons
(A) Endogenous neurotrophins are required for normal dendritic development in cortical pyramidal neurons. Representative camera lucida
reconstructions of neurons from untreated slices and slices treated with each of the Trk receptor bodies (20 mg/ml) are shown. Neutralizing
endogenous BDNF and NT-4/5 with TrkB±IgG (upper right) caused pronounced decreases in the growth of basal dendrites, while neutralizing
NGF with TrkA±IgG (lower left) had no significant effect compared to untreated neurons (upper left). Surprisingly, neutralizing NT-3 with
TrkC±IgG dramatically enhanced dendritic arbors (lower right). Blocking endogenous neurotrophins had no substantial effect on apical dendritic
growth. Scale bar, 30 mm.
(B) Opposite effects of endogenous BDNF and NT-3 on dendritic growth. Changes in dendritic complexity caused by treatment with each of
the receptor bodies (20 mg/ml) for basal (A) and apical (B) dendrites of pyramidal neurons in layer 4. Left graph: neutralizing endogenous
BDNF with TrkB±IgG decreased dendritic complexity by over 50% compared with untreated neurons, while neutralizing endogenous NGF
with TrkA±IgG had no effect on dendritic growth. Neutralizing endogenous NT-3 with TrkC±IgG markedly increased dendritic complexity, by
almost twofold. Right graph: neutralizing endogenous neurotrophins had little effect on growth of apical dendrites.
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Table 1. Summary of Data for Receptor Body Experiments in Layer 4
TrkB-IgG TrkA-IgG TrkC-IgG TrkB-IgG/BDNF TrkB-IgG/TrkC-IgG
(20 mg) (20 mg) (20 mg) (2 mg:200 ng) (20 mg:20 mg)
n 5 40 n 5 41 n 5 43 n 5 40 n5 41
TBD 0.9 1.00.5 1.9 0.5
#Prims 1.0 1.10.5 1.5 0.5
#Branches 0.8 1.1 0.50.4 2.5
#Pspines 0.9 1.00.5 1.5 0.7
% Change in DMI 0 0254% 84% 237%
TAD 0.9 1.2 0.90.8
#Branches 0.8 1.3 0.90.7
#Pspines 1.0 1.0 1.2 1.0
% Change in DMI 0 0210% 27%
The ratio of the average value for treated cells to the average untreated value for each parameter of dendritic growth. TBD 5 total length of
basal dendrites; TAD 5 total length of apical dendrites; #Prims 5 number of primary dendrites; #Branches 5 number of dendritic branches
off of the primary basal dendrites or the apical dendritic shaft; #Pspines 5 number of protospines. Boxes indicate values statistically significantly
different from litter-matched, untreated control values by single-factor ANOVA with a significance level of P # 0.05. Bold values indicate
significant decreases from control values.
addition of exogenous neurotrophins to augment neuro- layer 4 neurons, and 3) endogenous NT-3 limits dendritic
growth or induces dendritic retraction.trophin levels or by addition of Trk receptor bodies
(Trk±IgGs) to neutralize endogenous neurotrophins. The effects of TrkB±IgG and TrkC±IgG were dose-
dependent; TrkB±IgG first inhibited dendritic growth atTrk±IgGs are chimeric recombinant proteins consisting
of the ligand-binding domains of each of the Trk recep- 20 mg/ml while TrkC±IgG elicited growth even at 1 mg/ml.
All three receptor bodies were recoverable from treatedtors fused to the Fc domain of human IgG (Shelton et
al., 1995). These fusion proteins combine the stability slices at similar efficiencies (Figure 4A), indicating that
the stability of Trk±IgGs and their penetration into slicesand solubility of immunoglobulins with the high affinity
and specificity of native TrkA, TrkB, and TrkC recep- were similar in all cases, and that the absence of effect
of TrkA±IgG was not due to its degradation. The specific-tors, and are superior to function-blocking antibodies
in their ability to neutralize specific neurotrophins in ity of the Trk±IgGs was confirmed by competition with
BDNF: the growth-promoting effects of exogenousintact neural tissue.
BDNF were blocked by TrkB±IgG but not by TrkA±IgG
or TrkC±IgG (Figure 4B).Endogenous Neurotrophins Regulate Dendritic
Growth of Layer 4 Cortical Pyramidal Neurons
As expected from the extensive dendritic enhancement Opposing Actions of Endogenous BDNF and NT-3
on Dendritic Growth of Layer 4 Neuronselicited by exogenous TrkB ligands (Figure 1; see also
McAllister et al., 1995), neutralizing endogenous BDNF Neutralizing endogenous NT-3 caused dendritic growth
in layer 4 that was strikingly similar to that induced byand NT-4/5 with TrkB±IgG markedly reduced dendritic
complexity (Figure 2; Table 1) by causing retraction of exogenous BDNF (Figure 5). Neurons showed similar
increases in total dendritic length and in the number ofexisting basal dendrites (Figure 3); apical dendrites were
only modestly affected (Figure 2). In contrast, neutraliz- primary dendrites, higher-order dendritic branches, and
protospines (Table 2). Based on these similarities, weing endogenous NGF with TrkA±IgG had no effect on
basal dendrites (Figure 2), consistent with the minor hypothesized that the growth produced by blocking en-
dogenous NT-3 resulted from the actions of endogenouseffects of exogenous NGF on dendritic growth (McAllis-
ter et al., 1995). BDNF. If this were true, then dendritic growth caused
by TrkC±IgG should be prevented by neutralizing endog-As exogenous NT-3 caused no changes in dendritic
growth of layer 4 neurons (Figure 1; see also McAllister enous BDNF with TrkB±IgG.
In fact, treatment with both TrkC±IgG and TrkB±IgGet al., 1995), we predicted that neutralizing endogenous
NT-3 would also have little effect. Surprisingly, treatment completely abolished the dendritic growth caused by
TrkC±IgG treatment alone (Figure 6A), indicating thatwith TrkC±IgG elicited dramatic growth of basal den-
drites (Figure 2). Together, these effects of the Trk±IgGs the dendritic growth caused by TrkC±IgG treatment was
mediated by endogenous BDNF. Layer 4 neuronsindicated that 1) endogenous neurotrophins are biologi-
cally active in developing visual cortex, 2) endogenous treated with both receptor bodies had dendrites whose
complexity was intermediate between control and TrkB±TrkB ligands are necessary for basal dendritic growth of
Neuron
770
IgG-treated values. Dendritic growth of neurons treated
with both receptor bodies was decreased by 37% com-
pared to the 54% decrease resulting from treatment
with TrkB±IgG alone (these values were significantly dif-
ferent at the P , 0.05 level; Figure 6B).
These findings implied that exogenous BDNF and
NT-3 should also have opposing effects on dendritic
growth. Treatment of slices with both factors indicated
that this was true: the potent growth-promoting effects
of exogenous BDNF were abolished by equimolar levels
of exogenous NT-3 (Figure 7). Even at 10-fold lower
concentrations, NT-3 completely inhibited the effects of
exogenous BDNF in every parameter of dendritic growth
(Figure 8A; Table 3). These effects were specific to NT-3,
as cotreatment with NGF had no effect on the dendritic
growth caused by exogenous BDNF (Figure 8B).
Figure 3. Neutralizing Endogenous BDNF Results in Retraction of
Layer 4 Basal DendritesOpposing Effects of BDNF and NT-3 Are
Dendritic complexity was decreased by 36 hr of treatment with 20Reversed in Layer 6
mg/ml TrkB±IgG compared with the original morphology of neuronsIn layer 6, we previously found that dendritic growth
at the start of culture, indicating that retraction of layer 4 basal
was stimulated by exogenous NT-3 and inhibited by dendrites occurs when endogenous BDNF is neutralized. Dendritic
exogenous BDNF (McAllister et al., 1995). This led us to morphology at the beginning of the treatment period was assessed
suspect that opposing actions of BDNF and NT-3 might by fixing slices immediately following cutting and filling neurons
intracellularly with Lucifer Yellow (see McAllister et al., 1995). Meanalso be found in layer 6, butwith reversed roles. Remark-
values 6 SEM are plotted for the parameters of dendritic growthably, this turned out tobe the case: in layer 6, neutralizing
indicated. Neutralizing endogenous BDNF clearly decreased theendogenous NT-3 with TrkC±IgG decreased dendritic
total amount of basal dendrite and the number of primary dendrites,
complexity, while neutralizing endogenous BDNF with decreasing dendritic complexity overall by 49% in terms of the DMI.
TrkB±IgG increased dendritic growth (Figure 9). The
dendritic growth induced by exogenous NT-3 was re-
BDNF and NT-3 induced CREB phosphorylation in
markably similar to that caused by TrkB±IgG (Figure 9;
z50% of dissociated layer 4 cells (the maximum per-
Table 4), suggesting that the growth caused by neutraliz-
centage of cells capable of CREB phosphorylation as
ing endogenous BDNF was mediated by endogenous
assessed by forskolin 1 high potassium stimulation),
NT-3. If so, then the dendritic growth caused by TrkB±
while only 3% of untreated cells were phospho-CREB
IgG should be prevented by neutralizing endogenous
positive (Figure 11; Table 5). Consistent with observed
NT-3 with TrkC±IgG.
effects of NGF on dendritic growth (Figure 8B; see also
As predicted, treatment with both TrkC±IgG and TrkB±
McAllister et al., 1995), NGF also induced CREB phos-
IgG completely prevented the dendritic growth caused
phorylation in z50% of treated cells (Table 5). Untreated
by TrkB±IgG alone (Figures 9 and 10A), indicating that
cells were at most only lightly stained for phospho-
the dendritic growth elicited by TrkB±IgG was mediated
CREB, while most of the stained, treated cells were
by endogenous NT-3. Layer 6 neurons treated with both
clearly darkly stained (Figure 11; Table 5). Most impor-
receptor bodies were almost indistinguishable from
tantly, treatment of cells with BDNF and NT-3 together
control neurons, suggesting that endogenous BDNF
did not increase the percentage of phospho-CREB posi-
causes retraction of basal dendrites, while endogenous
tive cells over that observed after treatment with either
NT-3 induces dendritic growth. Exogenous BDNF and
factor alone (Figure 11; Table 5), indicating that BDNF
NT-3 also had opposing effects on dendritic growth of
and NT-3 act directly onmostly overlapping, if not identi-
layer 6 neurons: even a 10-fold lower concentration of
cal, neuronal populations in layer 4.
exogenous BDNF completely blocked the dendritic
growth induced by exogenous NT-3 (Figures 9 and 10B; Discussion
Table 4).
These results demonstrate that endogenous neurotro-
BDNF and NT-3 Act Directly on Layer 4 Neurons phins are biologically active in developing visual cortex
To examine whether BDNF and NT-3 could act directly and that they can either stimulate or inhibit dendritic
on layer 4 pyramidal neurons, or whether they must growth. Moreover, endogenous BDNF and NT-3 can act
affect dendritic growth in layer 4 via other cell types directly upon the same neuronal populations and have
present in cortex, acutely-dissociated layer 4 neurons opposing effects on dendritic growth. In layer 4, BDNF
were assessed for phosphorylation of cAMP-response stimulates dendritic growth, while NT-3 inhibits dendritic
element binding protein (CREB) in response to neuro- growth. These roles for BDNF and NT-3 are reversed in
trophins (Ginty et al., 1993; Ghosh et al., 1994). CREB the regulation of dendritic growth in layer 6.
phosphorylation occurs downstream of activation of all
three Trk receptors and serves as an index of neuro- Endogenous Neurotrophins Regulate Dendritic
trophin responsiveness. CREB phosphorylation was de- Growth of Cortical Pyramidal Neurons
tected using an antibody specific for CREB phosphory- As suggested by the strong effects of exogenous neuro-
trophins on the dendritic growth of cortical pyramidallation at serine-133 (Ginty et al., 1993).
Opposing Effects of BDNF and NT-3 on Dendritic Growth
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Figure 4. Penetration and Specificity of Trk
Receptor Bodies
(A) Trk receptor bodies penetrate cultured
slices and remain intact. Trk±IgGs were re-
covered from cultured slices treated for 36
hr with 20 mg/ml of each receptor body by
homogenization and extraction of Trk±IgGs
with Protein-G agarose, as described in the
Experimental Procedures. Recovered pro-
teins were separated by SDS-PAGE and im-
munoblotted with an anti-human IgG anti-
body to visualize Trk±IgGs. The upper band
with apparent molecular weight of 92 kDa
corresponds to the Trk±IgGs and is not pres-
ent in homogenates of untreated (UT) slices;
the lower band at z50 kDa is non-specific
and is present in all slices regardless of treat-
ment. The similarity of recovery of TrkA±IgG,
TrkB±IgG, and TrkC±IgG indicated that these
receptor bodies penetrated slices to equiva-
lent degrees and remained intact during the
treatment period. No proteolytic fragments
containing the human IgG Fc domain of the
receptor body were observed.
(B) TrkB±IgG, but not TrkA±IgG or TrkC±IgG,
inhibits the effects of exogenous BDNF. The
specificity of each of the receptor bodies was
assayed by their ability to inhibit the growth-
promoting effects of exogenous BDNF on
layer 4 neurons. TrkB±IgG showed dose-
dependent inhibition of the effects of 200 ng/
ml of BDNF, with complete inhibition oc-
curring at an equimolar equivalent of TrkB±
IgG (2 mg/ml, shown in bold, left); a 10-fold
lower concentration of TrkB±IgG had no in-
hibitory effect. In contrast, even at 10-fold
molar excess (22 mg/ml), neither TrkA±IgG nor
TrkC±IgG inhibited the dendritic growth stim-
ulated by exogenous BDNF (right).
neurons (Figure 1; see also McAllister et al., 1995), we that calculated for BDNF in adult pig brain (Hofer and
Barde, 1988), which may reflect local actions of endoge-found that endogenous neurotrophins are required for
normal dendritic development. Consistent with the nous BDNF that require higher concentrations of TrkB±
IgG for neutralization. In any case, these estimates arelayer-specific effects of exogenous neurotrophins, den-
dritic growth of layer 4 neurons requires endogenous upper bounds because of immeasurable factors such as
internalization or degradation of receptor bodies, whichBDNF, while growth of layer 6 cells requires endogenous
NT-3. Despite their involvement in basal dendritic would cause us to overestimate the active concentra-
tions of Trk±IgGs in treated slices.growth and the effects of exogenous neurotrophin appli-
cation, endogenous neurotrophins do not appear to reg-
ulate apical dendritic growth. This difference of growth Endogenous Neurotrophins Inhibit As Well
As Stimulate Dendritic Growthregulation in apical versus basal dendritic compart-
ments is consistent with our previous observations us- Although neurotrophins are generally considered to be
growth-promoting factors, we found, surprisingly, thating exogenous neurotrophins (McAllister et al., 1995).
Recovery of intact Trk receptor bodies from treated endogenous NT-3 in layer 4 and BDNF in layer 6 both
strongly inhibited basal dendritic growth. Moreover,slices (Figure 4A) allowed us to estimate an upper bound
for the effectivephysiological concentrationsof endoge- since neutralizing both BDNF and NT-3 resulted in den-
dritic complexities intermediate to those values causednous neurotrophins. Penetration of slices was similar
for all receptor bodies; at the concentrations used in by neutralizing either factor alone, the growth-inhibitory
effects of neurotrophins are likely to involve active re-Figure 4A (20 mg/ml), each slice was estimated to con-
tain z2.5 ng of Trk±IgGs at the end of the treatment traction of dendrites. For example, Figure 10A illustrates
two conditions in which endogenous NT-3 was neutral-period. Since Trk±IgGs neutralize neurotrophins at equi-
molar ratios, we calculated the active concentration of ized: treatment with TrkC±IgG alone and treatment with
TrkB±IgG and TrkC±IgG together. The only differenceneurotrophins corresponding to the threshold doses of
Trk±IgGs required for affecting dendritic growth (20 mg/ between these two conditions is that endogenous BDNF
is still active in the presence of TrkC±IgG alone. Sinceml for TrkB±IgG and 1 mg/ml for TrkC±IgG). Assuming
an extracellular volume of 10%, we estimate that 250 the dendrite modification index (DMI) is decreased in
this condition, the simplest interpretation is that endoge-ng/ml BDNF and 13 ng/ml NT-3 are active in developing
cortical tissue. The estimate for BDNF is higher than nous BDNF caused retraction of existing dendrites.
Neuron
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Figure 5. Neutralizing Endogenous NT-3 and
Adding Exogenous BDNF Cause Similar Den-
dritic Enhancement
Camera lucida reconstructions of the basal
dendritic arborizations of layer 4 neurons
from slices treated with either TrkC±IgG (20
mg/ml) or BDNF (200 ng/ml). Neurons de-
picted for each treatment represent the range
of morphologies across the sampled popula-
tions. Neutralizing endogenous NT-3 elicited
elongation and sprouting of new primary den-
drites, similar to that induced by exogenous
BDNF. This suggested that blocking endoge-
nous NT-3 releases endogenous BDNF from
inhibition, allowing endogenous BDNF to ex-
ert its effects on dendritic growth. Scale bar,
20 mm.
BDNF and NT-3 Have Opposing Roles One explanation for these results is that NT-3 and
BDNF directly interact by competing for binding to TrkB.in Regulating Dendritic Growth
Most importantly, we found that endogenous BDNF and TrkB can act as a receptor for NT-3 (Maisonpierre, 1990;
Glass et al., 1991; Klein et al., 1991; Soppet et al., 1991;NT-3 have opposing effects on dendritic growth in layer
4 and layer 6 pyramidal neurons, suggesting that BDNF Squinto et al., 1991; Rodriguez-Tebar et al., 1992) and
can inhibit BDNF-mediated neuronal survival (Dechantand NT-3 are part of a ªpush-pullº signaling system that
regulates dendritic development of individual neurons et al., 1993). In most cases, NT-3 binds to TrkB with
lower affinity than BDNF (Maisonpierre et al., 1990; Kleinin response to multiple environmental cues. Although
the loci of action of endogenous BDNF and NT-3 remain et al., 1991; Altar et al., 1994; but see also Ip et al.,
1993), and physiological concentrations of NT-3 do notto be determined, two observations make it likely that
these neurotrophins both act directly on layer 4 and appreciably activate TrkB in neuronal cell contexts (Ip
et al., 1993). Most relevant to our study, NT-3 does notlayer 6 neurons: 1) in acutely-dissociated layer 4 neu-
rons, BDNF and NT-3 together induced CREB phosphor- significantly cross-link to TrkB in P10 ferret visual cortex
(Allendoerfer et al., 1994). The possibility of receptor-ylation to the same extent as either factor alone, indicat-
ing that largely overlapping or identical populations of based competition is further diminished by our finding
that even at a concentration 10-fold lower than that ofneurons respond to both factors (Figure 11); and 2) the
actions of BDNF and NT-3 are reversed in layer 6 com- BDNF, NT-3 completely inhibits BDNF-induced growth
of layer 4 neurons (Figure 8). These observations sug-pared with layer 4, i.e., BDNF is stimulatory and NT-3
inhibitory in layer 4, while NT-3 is stimulatory and BDNF gest that the opposing actions of BDNF and NT-3 in
developing cortex are not likely tooccur throughcompe-inhibitory in layer 6 (Figures 6, 9, and 10).
tition at the receptor, but rather through interactions at
subsequent stages of signal transduction (reviewed byTable 2. Neutralizing Endogenous NT-3 and Adding Exogenous
BDNF Cause Similar Dendritic Growth Kaplan and Stephens, 1994).
Regardless of the mechanism of their interaction, theTrkC-IgG BDNF
reversal of BDNF and NT-3 effects between layers 4 and(20 mg/ml) (200 ng/ml)
6 is likely to involve phenotypic differences betweenn 5 43 n 5 40
neurons in these two cortical layers, leading to divergentTotal Basal Dendrite
responses to the same neurotrophin signals. There are(mm/10) 190% 190%
strong precedents for such cell-contextual differences#Primary Dendrites 150% 170%
#Dendritic Branches 1150% 1100% affecting the biological actions of neurotrophins. For
#Protospines 150% 1100% example, neurotrophins are differentiative when acting
% Change in DMI 192% 184% through Trk receptors expressed in neuronal cells, but
mitogenic when acting through Trk receptors expressedChange in the average value for each parameter of dendritic growth
compared to untreated control values. All values were statistically in nonneuronal cells such as fibroblasts (e.g., Ip et al.,
significantly different from untreated control vlaues by single-factor 1993). During peripheral nervous system development,
ANOVA with a significance level of P # 0.001. Conventions as in neurotrophins function as trophic factors for mature
Table 1.
ganglionic neurons but areoften mitogenic for precursor
Opposing Effects of BDNF and NT-3 on Dendritic Growth
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Figure 6. TrkB±IgG Blocks the Dendritic
Growth Induced by TrkC±IgG in Layer 4
Neurons
(A) Camera lucida reconstructions of basal
dendritic arbors for layer 4 neurons from con-
trol slices and slices treated with either TrkC±
IgG, TrkB±IgG, or both Trk±IgGs together (20
mg/ml each). Basal dendritic arbors of neu-
rons treated with both TrkB±IgG and TrkC±
IgG were clearly reduced in complexity com-
pared with TrkC±IgG-treated cells; they were
also reduced compared with untreated neu-
rons. These arbors resembled those of TrkB±
IgG-treated neurons. Scale bar, 20 mm.
(B) Blocking endogenous TrkB ligands pre-
vents dendritic growth caused by neutralizing
endogenous NT-3. Changes indendritic com-
plexity (DMI) for neurons from slices treated
with either TrkB±IgG alone, TrkC±IgG alone,
or both Trk±IgGs together. Blocking endoge-
nous TrkB ligands with TrkB±IgG completely
prevented the increase in dendritic complex-
ity caused by neutralizing endogenous NT-3
with TrkC±IgG. Treatment with both Trk±IgGs
caused dendritic retraction compared with
untreated neurons, but not to the full extent
caused by treatment with TrkB±IgG alone.
cells to the same ganglia (e.g., Catteneo and McKay, In summary,our results demonstrate that endogenous
neurotrophins are necessary for regulating dendritic1990; Kalcheim et al.,1992; Kalcheim, 1996). By analogy,
since neurons in different cortical layers are phenotypi- growth of pyramidal neurons in developing ferret visual
cortex. Moreover, neurotrophins clearly function in bothcally distinct, it isplausible that differences in their signal
transduction systems and patterns of gene expression positive and negative directions to regulate dendritic
growth. Such a push-pull system for regulating dendriticcould lead to quite different dendritic growth responses
to the same neurotrophin signals. growth is reminiscent of the interactions between, and
Neuron
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Figure 8. NT-3, but Not NGF, Prevents Dendritic Growth Elicited by
Exogenous BDNF
Changes in dendritic complexity (DMI) for neurons from slices
treated with either NT-3, BDNF, or NT-3 and BDNF together, at the
indicated concentrations (A), and either NGF (200 ng/ml), BDNF (200
ng/ml), or NGF and BDNF together (B).
(A) Even a 10-fold lower concentration of exogenous NT-3 (20 ng/ml)
completely blocked the enhancement of dendritic complexity by
200 ng/ml of BDNF.
(B) Exogenous NGF had no effect on the dendritic enhancement
elicited by exogenous BDNF.
Figure 7. Exogenous NT-3 Blocks Dendritic Growth Elicited by Ex-
ogenous BDNF
Camera lucida reconstructions of basal dendritic arbors of layer 4
1995, 1996). Culture medium (1 ml; 50% BME, 25% HBSS, 25%neurons from untreated slices and slices treated with either BDNF
horse serum [Hyclone], 330 mM dextrose, 10 mM HEPES, and(200 ng/ml), NT-3 (200 ng/ml), or both neurotrophins together. BDNF
10 U/ml penicillin-streptomycin; GIBCO) was placed under eachtreatment caused striking growth of basal dendrites while NT-3 had
insert, and the plates were incubated in 5% CO2 at 378C for 36 hr.minimal effects on dendritic growth (see also McAllister et al., 1995).
Ferrets were obtained from Marshall Farms (North Rose, NY).
However, when slices were treated with both factors together, exog-
enous NT-3 blocked the growth-promoting effects of exogenous
Particle-Mediated Gene TransferBDNF. Dendritic arbors of neurons treated with both factors were
Particle-mediated gene transfer was used to visualize large numberssimilar to those of untreated cells and distinct from those of BDNF-
of neurons in the slices; details of the procedure have been pre-treated cells. Scale bar, 20 mm.
viously described (Lo et al., 1994; McAllister et al., 1995). Particle-
mediated gene transfer of EFbgal (lacZ driven by the Xenopus EF1a
the importance of cell context for, stimulators and inhibi- promoter [Krieg et al., 1989]) was performed within 1±4 hr after
tors of axon guidance (reviewed by Tessier-Lavigne and slice preparation, using a Bio-Rad PDS-1000/He biolistics device.
Following transfection, slices were returned to the incubator andGoodman, 1996). Although the neurotrophins have gen-
maintained for 36 hr in the presence or absence of neurotrophinerally been considered to have similar biological roles,
and/or receptor bodies.our results indicate that BDNF and NT-3 have distinct
actions on dendritic growth, acting perhaps as compo-
Neurotrophins and Receptor Bodiesnents of an integrative signaling system for neuronal
Human recombinant met-BDNF and NT-3, TrkA±IgG, TrkB±IgG, and
development and certainly not as independent, redun- TrkC±IgG were generously provided by Regeneron Pharmaceuticals
dant growth factors. Such reciprocal actions of neuro- (Tarrytown, NY). Purified 2.5S mouse NGF was purchased from Col-
trophins and other peptide signaling factors may well laborative Biochemical. Neurotrophins and/or receptor bodies were
added to the medium immediately following particle-mediated genebe important for many aspects of neuronal development
transfer.and function throughout the brain.
Experimental Procedures Immunocytochemistry
Transfected neurons were visualized by immunocytochemistry us-
ing an affinity-purified rabbit antibody to b-galactosidase (1:500;Preparation of Visual Cortex Slice Cultures
Coronal slices (400 mm) of P14 ferret visual cortex were prepared 59-39) and a Cy3-conjugated goat anti-rabbit secondary antibody
(1:100; Chemicon), as previously described (McAllister et al., 1995).and cultured as previously described (Katz, 1987; McAllister et al.,
Opposing Effects of BDNF and NT-3 on Dendritic Growth
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Table 3. NT-3 Blocks the Increases in Dendritic Growth Caused by BDNF in Layer 4 while NGF Does Not
NT-3 BDNF NGF NGF/BDNF NT-3/BDNF
(200) (200) (200) (200:200) (20:200)
n 5 40 n 5 40 n 5 40 n 5 39 n 5 40
Total Basal Dendrite (mm/10) 1.3 0.91.9 1.4 1.7
#Primary Dendrites 1.3 1 1.11.7 2.3
#Dendritic Branches 1.3 1 0.82 1.7
#Protospines 1.3 0.81.5 2 1.8
% Change in DMI 0110% 192% 119% 181%
The 92% increase in basal dendrites elicited by BDNF is completely blocked by 20 ng/ml NT3 (last column) but not significantly affected by
200 ng/ml NGF (fourth column). Conventions as in Table 1.
Slices were counterstained with 100 mM DAPI (49,6-diamidino-2- dendrite (mm) and the numbers of primary dendrites, branches of
each dendrite, and protospines (spine-like processes less than 0.5phenylindole) to determine the layer-specific location of each
neuron. mm), as previously described (McAllister et al., 1995).
Cell Selection, Reconstruction, and Analysis Calculation of the DMI
For each experimental condition, z40 cells from two ferrets, each The DMI summarizes the average of the four parameters for each
from a separate litter, were used. Control cells (40±60) were always treatment into a value that conveys the direction and magnitude of
obtained from animals in each litter to facilitate comparison with resulting dendritic changes. The DMI is simply a weighted sum of
experimentally treated cells. The first 40 pyramidal neurons that the ratios for each of the four measures of dendritic growth in treated
were stained sufficiently to distinguish the smallest processes were versus untreated cells, calculated as:
reconstructed with a camera lucida using a 633 objective and a
DMI 5 o
i
Ci ´ Ti/UTistandard rhodamine epifluorescence filter set on a Zeiss Axiophot
microscope. From these drawings, four parameters of dendritic
growth were directly measured or counted: the total length of each where Ti is the value of a given parameter i after treatment, UTi is the
Figure 9. Opposing Actions of BDNF and
NT-3 in Regulating Dendritic Growth of Layer
6 Neurons
Camera lucida reconstructions of basal den-
dritic arbors of neurons from untreated slices
and slices treated with Trk±IgGs (20 mg/ml)
and exogenous neurotrophins (200 ng/ml), as
indicated. Neutralizing endogenous NT-3
with TrkC±IgG decreased dendritic growth,
while neutralizing endogenous TrkB ligands
with TrkB±IgG enhanced dendritic growth.
TrkC±IgG completely prevented the dendritic
growth elicited by TrkB±IgG when both re-
ceptor bodies were added together. Exoge-
nous BDNF and NT-3 interacted similarly.
Treatment with BDNF alone decreased den-
dritic elaboration, while treatment with NT-3
alone enhanced dendritic growth; NT-3-
induced dendritic growth was completely
prevented by exogenous BDNF. Scale bar,
30 mm.
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Table 4. Summary of Data for Receptor Body Experiments in Layer 6
TrkB-IgG 1
TrkB-IgG TrkC-IgG TrkC-IgG NT-3 BDNF NT-3 1 BDNF
(20 mg) (20 mg) (20 mg:20 mg) (200 ng) (200 ng) (200 ng:20 ng)
n 5 40 n 5 30 n 5 40 n 5 40 n 5 40 n 5 40
Total Basal Dendrite (m/10) 0.82.0 0.5 0.7 1.5 0.6
#Primary Dendrites 1.0 0.92.4 0.7 0.7 0.8
#Dendritic Branches 0.7 1.33.4 0.5 0.7 0.4
#Protospines 0.8 0.92.2 0.5 2.4 0.5
% Change in DMI 1139% 244% 211% 130% 220% 239%
In layer 6, the roles of BDNF and NT3 are reversed. The ratio of the average value for treated cells to the average untreated value for each
parameter of dendritic growth. Conventions as in Table 1.
value in untreated slices, and Ci is a normalized weighting constant any individual parameter of dendritic growth, each T/UT value is set
to 1, resulting in a DMI for that experimental condition equal to 1.whose magnitude depends on the parameter (see McAllister et al.,
1995 for additional details). The ratio T/UT is set to a value of 1 for Similarly, for an experimental condition that doubles the values for
each parameter of dendritic growth in a statistically significant man-cases in which treated values (T) are not significantly different from
control values (UT) at the P , 0.05 confidence level by ANOVA. For ner, the resulting DMI will be equal to 2. Statistical significance is
thus intrinsic to the DMI calculation, and error bars are not shownan experimental condition with no statistically significant effect on
in graphs of DMI values.
Recovery of Receptor Bodies from Treated Slices
Slices were cultured and treated with 20 mg/ml of each of the recep-
tor bodies as described.After 36 hr in vitro, slices were homogenized
in 100 ml cell lysis buffer (Ip et al., 1993; 0.14 U/ml aprotonin, 1 mM
PMSF, 1 mM Na orthovanadate, 1% NP-40, 0.5% deoxycholate,
and 0.1% SDS in calcium- and magnesium-free PBS). Cell debris
was removed by brief centrifugation; supernatant was removed and
incubated with 1/2 volume washed Protein G agarose (GIBCO) at
48C for 1 hr, with rocking. Beads were then collected by centrifuga-
tion and run on 7.5% polyacrylamide gels with receptor body and
molecular weight standards in parallel lanes. Gels were transferred
onto PVDF paper (Bio-Rad) and blocked with PBS containing 0.05%
Tween and 5% BSA. Trk receptor bodies were then visualized by
immunoblotting with a goat anti-human IgG antibody (1:500; Boeh-
ringer-Mannheim) followed by an alkaline phosphatase-conjugated
anti-goat IgG antibody (1:500, Boehringer Mannheim). Chemilumi-
nescence was generated using the CDP-Star substrate (New En-
gland BioLabs) and detected with Hyperfilm-ECL (Amersham).
Table 5. BDNF and NT-3 Act Directly on Layer 4 Neurons
%Stained Cells
(Average 6 SEM)
Untreated 3 1 0.3
KCl (60 mM) 1 Forskolin (10 mM) 57 1 3.0
NT-3 (200 ng/ml) 51 1 0.3
BDNF (200 ng/ml) 48 1 3.5
NGF (200 ng/ml) 48 1 2.3
NT-3 1 BDNF (200:200) 53 1 1.8
NT-3 1 BDNF (200:20) 53 1 1.5
NT-3 1 BDNF (20:200) 51 1 3.2
Figure 10. Opposing Effects of NT-3 and BDNF in Layer 6
Responsiveness to neurotrophins as assessed by phosphorylation
Changes in dendritic complexity (DMI) for neurons from slices of CREB in acutely dissociated layer 4 cells. Mean 6 SEM percent-
treated with Trk±IgGs and exogenous neurotrophins, as indicated. age of stained cells from a full diameter of each of three coverslips.
(A) Increases in dendritic complexity elicited by neutralizing endoge- Means of all treated cells differed significantly from the means of
nous TrkB ligands with TrkB±IgG were completely prevented by untreated cells (bold) but not significantly from each other. Total
blocking endogenous NT-3 with TrkC±IgG. Conversely, the de- numbers of cells counted: untreated 5 880, 460, 457; KCl 1
creases in dendritic complexity caused by TrkC±IgG were largely forskolin 5 425, 434, 660; NT-3 5 416, 640, 471; BDNF 5 543, 324,
prevented by TrkB±IgG. 490; NGF 5 664, 441, 460; NT-3 1 BDNF (200:200) 5 664, 441, 460;
(B) Exogenous BDNF completely prevented the large increases in NT-3 1 BDNF (200:20) 5 562, 508, 373; NT-3 1 BDNF (20:200) 5
dendritic complexity elicited by NT-3 (200 ng/ml), even at a 10-fold 390, 368, 304.
lower concentration of BDNF (20 ng/ml).
Opposing Effects of BDNF and NT-3 on Dendritic Growth
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Figure 11. BDNF and NT-3 Act Directly on Layer 4 Neurons
Two hours after acute dissociation, layer 4 neurons were treated with either 60 mM KCl 1 10 mM forskolin for 5 min, or 200 ng/ml BDNF, 200
ng/ml NT-3, or combinations of the neurotrophins as indicated for 30 min. Neurons were immediately fixed and stained with an antibody
against phosphorylated CREB to determine their ability to respond to neurotrophins.
(A) Representative dissociated layer 4 neurons from each of the treatments. KCl 1 forskolin, BDNF, and NT-3 all caused phosphorylation of
CREB, as indicated by the darkly stained nuclei in these photomicrographs. Thus, layer 4 neurons respond directly to both BDNF and NT-3.
(B) Percentage of neurons staining positive for phospho-CREB following each treatment. Both BDNF and NT-3 induced CREB phosphorylation
in about half of the cells, while few untreated cells stained positive for phospho-CREB. Treatment with both BDNF and NT-3 did not increase
numbers of phospho-CREB positive cells over those induced by either factor alone, indicating that BDNF and NT-3 act on largely overlapping,
if not identical, populations of neurons in layer 4.
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